WindRose Health Investors Acquires CardioOne
March 4, 2024
WindRose Health Investors has completed the acquisition of CardioOne, a physician-enablement company serving independent cardiologists, and partnered with CardioOne's executive team to provide up to $100 million of additional capital to support growth. CardioOne's existing management will remain in place and the investment will fund expansion and enhancement of its technology platform and service offerings as the company prepares for value-based care.
- Buyers
- WindRose Health Investors, LLC
- Targets
- CardioOne Inc.
- Industry
- Healthcare Services
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CardioOne Acquires CardioDiagnostics
April 24, 2025
Healthcare Services
CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.
-
WindRose Health Investors Makes Majority Growth Investment in SubjectWell
April 30, 2024
Healthcare Services
WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.
-
WindRose Health Investors Recapitalizes Bluestone Physician Services
April 14, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.
-
WindRose Health Investors Recapitalizes RevHealth
July 27, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
-
WindRose Health Investors Recapitalizes Healthmap Solutions
May 21, 2019
Healthcare Services
WindRose Health Investors completed an $85 million equity recapitalization of Healthmap Solutions to provide growth capital and support the company's expansion into new markets. Healthmap, a specialty population health management firm focused on kidney disease, will continue to be led by CEO Joe Vattamattam and COO & Founder Andrew Wall.
-
Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health
February 3, 2025
Healthcare Services
Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.